MHRA Requests Feedback Ahead of Brexit
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) is conducting a survey to better understand how it can support its customers in the run up to the country’s exit from European Union.
MHRA is embarking on a major operational transformation scheme across its three expert centers: the MHRA regulatory center, the National Institute for Biological Standards and Control, and the Clinical Practice Research Datalink. This includes significant investment in the organization’s digital capabilities and infrastructure, it noted.
The survey should take about 10-15 minutes to complete, depending on how many different parts of the agency an individual deals with. All responses will be held in strict confidence and will not be passed on to the agency in a way that would allow any individual contribution to be identified, according to the survey organizers.
According to the MHRA, “understanding your needs and priorities is essential to inform our plans and will help us to strategically shape our services, investment decisions, and underlying operational processes and systems. The work we do now will underpin how we are able to meet your needs for years to come.”
The survey was designed in collaboration with PA Consulting, a consulting, technology, and innovation firm, and Woodnewton Associates, an independent strategic research agency. It closes on Wednesday September 27. To complete it, click here.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
